Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in United States Virgin Islands
United States Virgin Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.2% in 2024. ▼ Falling
Latest (2024)
0.2%
Change on year
unchanged
World rank
78th
of 215 countries
All-time high
0.4%
in 2015
All-time low
0.2%
in 2018
Years of data
10
2015–2024
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in United States Virgin Islands, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
United States Virgin Islands recorded 0.2% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 50.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in United States Virgin Islands peaked at 0.4% in 2015 and was at its lowest, 0.2%, in 2018.
United States Virgin Islands ranks 78th of 215 countries on this measure, in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in United States Virgin Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.4% | — |
| 2016 | 0.3% | -25.0% |
| 2017 | 0.3% | +0.0% |
| 2018 | 0.2% | -33.3% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.2% | +0.0% |
| 2021 | 0.2% | +0.0% |
| 2022 | 0.2% | +0.0% |
| 2023 | 0.2% | +0.0% |
| 2024 | 0.2% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.4% | 5 |
| 2020s | 0.2% | 0.2% | 0.2% | 5 |
Countries ranked near United States Virgin Islands
- 78 Anguilla 0.2% compare
- 78 Antigua and Barbuda 0.2% compare
- 78 Aruba 0.2% compare
- 78 Bahamas 0.2% compare
- 78 Barbados 0.2% compare
- 78 Bonaire, Sint Eustatius and Saba 0.2% compare
- 78 British Virgin Islands 0.2% compare
- 78 Cayman Islands 0.2% compare
- 78 Curaçao 0.2% compare
- 78 Dominica 0.2% compare
- 78 Fiji 0.2% compare
- 78 Grenada 0.2% compare
- 78 Guadeloupe 0.2% compare
- 78 India 0.2% compare
- 78 Jamaica 0.2% compare
- 78 Kazakhstan 0.2% compare
- 78 Libya 0.2% compare
- 78 Maldives 0.2% compare
- 78 Martinique 0.2% compare
- 78 Montserrat 0.2% compare
- 78 Nepal 0.2% compare
- 78 North Macedonia 0.2% compare
- 78 Pakistan 0.2% compare
- 78 Puerto Rico 0.2% compare
- 78 Saint Barthélemy 0.2% compare
- 78 Saint Kitts and Nevis 0.2% compare
- 78 Saint Lucia 0.2% compare
- 78 Saint Martin (French part) 0.2% compare
- 78 Saint Vincent and the Grenadines 0.2% compare
- 78 Sint Maarten (Dutch part) 0.2% compare
- 78 Suriname 0.2% compare
- 78 Tajikistan 0.2% compare
- 78 Turks and Caicos Islands 0.2% compare
More development goals data for United States Virgin Islands
- Red List Index 0.729 (2025)
- Number of transboundary breeds 1 (2025)
- Number of transboundary breeds (not extinct) 1 (2025)
- Number of transboundary breeds with unknown risk status 1 (2025)
- Number of local breeds with unknown risk status 1 (2025)
- Number of local breeds (not extinct) 1 (2025)
- Number of local breeds kept in the country 1 (2025)
- Alcohol consumption per capita (aged 15 years and older) within a 20.1 (2024)
- Domestic material consumption, by type of raw material 366.08 (2024)
- DEC alternative conversion factor 1 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in United States Virgin Islands?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in United States Virgin Islands was 0.2% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in United States Virgin Islands?
- The highest recorded value was 0.4% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in United States Virgin Islands?
- The lowest recorded value was 0.2% in 2018.
- How does United States Virgin Islands rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- United States Virgin Islands ranks 78th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in United States Virgin Islands?
- Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
- Where does this United States Virgin Islands data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).